Camargo Pharmaceutical Services‘ chief executive officer, Ken Phelps, will be traveling to Tokyo, Seoul, Taipei, and Mumbai throughout this month.    Phelps plans to hold seminars in each city on 505(b)(2) drug development, as well as meet with leading companies. This trip follows a prior trip to China, during which Camargo held a seminar with the U.S. Food and Drug Administration (FDA) on American regulatory issues, and builds on the global nature of Camargo’s clients.  ...